This is the text extract for May Tender Notification; Contact: Notifications, browse documents here.

---

31 May 2011

TENDER RESULTS

The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2009/10 Invitation to Tender, dated 4 December 2009 and the 2010/11 Invitation to Tender, dated 2 November 2010. As discussed in our 2010 tender consultation document, we are notifying tender decisions as they are made in 2011. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp.

A422134 - qA18036

Page 1 of 10

---

2010/11 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2014 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows: Chemical name Presentation; Pack size and type Eye oint 0.1%; 3.5 g tube, OP Inj 25 mg per ml, 3 ml; 5 ampoules Suppos 12.5 mg; 10 suppositories, blister Suppos 25 mg; 10 suppositories, blister Suppos 50 mg; 10 suppositories, blister Suppos 100 mg; 10 suppositories, blister Eye drops 1 mg per ml, 5 ml; 5 ml bottle, OP Tab 600 mcg; 100 tablets, bottle TDDS 5 mg; 30 patches, sachet TDDS 10 mg; 30 patches, sachet Eye drops 0.1%; 10 ml bottle, OP Current subsidy and price $5.86 $12.00 $1.85 $2.22 $3.84 $6.36 $13.80 $8.00 $16.56 $19.60 $8.71 New subsidy and price $5.86 $12.00 $1.85 $2.22 $3.84 $6.36 $13.80 $8.00 $16.56 $19.50 $8.71 Sole supply brand (Supplier) Maxidex (Alcon) Voltaren (Novartis) Voltaren (Novartis) Voltaren (Novartis) Voltaren (Novartis) Voltaren (Novartis) Voltaren Ophtha (Novartis) Lycinate (Sigma) Nitroderm TTS (Novartis) Nitroderm TTS (Novartis) Lomide (Alcon) Date of subsidy change Sole Subsidised Supply date

Dexamethasone Diclofenac sodium Diclofenac sodium Diclofenac sodium Diclofenac sodium Diclofenac sodium Diclofenac sodium Glyceryl trinitrate Glyceryl trinitrate Glyceryl trinitrate Lodoxamide trometamol

1 July 2011 -

1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011

A422134 - qA18036

Page 2 of 10

---

Chemical name Metoclopramide hydrochloride Naphazoline hydrochloride Paracetamol

Presentation; Pack size and type Inj 5 mg per ml, 2 ml; 10 ampoules Eye drops 0.1%; 15 ml bottle, OP Oral liq 250 mg per 5 ml; 1,000 ml bottle Inj 1 mg per ml, 1 ml; 1 ampoule Inj 250 µg; 10 ampoules Eye drops 0.5%; 15 ml bottle, OP Eye drops 1%; 15 ml bottle, OP Tab 40 mg; 100 tablets, blister Tab 80 mg; 100 tablets, blister

Current subsidy and price $4.50 $4.15

New subsidy and price $4.50 $4.15

Sole supply brand (Supplier) Pfizer (Pfizer) Naphcon Forte (Alcon) Paracare Double Strength (API) Synacthen Depot (Novartis) Synacthen (Novartis) Mydriacyl (Alcon) Mydriacyl (Alcon) Isoptin (Abbott) Isoptin (Abbott)

Date of subsidy change

Sole Subsidised Supply date

-

1 October 2011 1 October 2011

$7.00

$6.70

1 July 2011

1 October 2011

Tetracosactrin Tetracosactrin Tropicamide Tropicamide Verapamil hydrochloride Verapamil hydrochloride

$26.88 $177.18 $7.15 $8.66 $7.01 $11.74

$29.56 $177.18 $7.15 $8.66 $7.01 $11.74

1 July 2011 -

1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011

A422134 - qA18036

Page 3 of 10

---

2.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

Date of listing/subsidy change for tender winning brand 1 November 2011 1 November 2011 1 November 2011 Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 April 2012 1 April 2012 1 April 2012 Pacific (Mylan) Pacific (Mylan) Pacific (Mylan) Nitrolingual Pumpspray (Douglas) Cozaar (MSD) Cozaar (MSD) Cozaar (MSD) Cozaar (MSD) Hyzaar (MSD) Paracare Junior (API) Pharmacare (API)

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Cap 50 mg; 28 capsules, blister Cap 150 mg; 1 capsule, blister Cap 200 mg; 28 capsules, blister Spray 400 mcg per dose; 250 dose aerosol spray Tab 12.5 mg; 90 tablets, blister Tab 25 mg; 90 tablets, blister Tab 50 mg; 90 tablets, blister Tab 100 mg; 90 tablets, blister Tab 50 mg; 30 tablets, blister Oral liq 120 mg per 5 ml; 500 ml bottle Tab 500 mg; 1,000 tablets, blister

Current subsidy and price $6.82 $1.30 $19.05

New subsidy and price $4.77 $0.91 $13.34

Sole supply brand (Supplier) Flucoran (Douglas) Flucoran (Douglas) Flucoran (Douglas) Glytrin (AFT) Lostaar (Mylan) Lostaar (Mylan) Lostaar (Mylan) Lostaar (Mylan) Arrow-Losartan & Hydrochlorothiazide (Arrow)

Date of reference pricing of other listed brands 1 January 2012 1 January 2012 1 January 2012

Fluconazole Fluconazole Fluconazole

Glyceryl trinitrate

$5.16 $17.40 (30 tablets) $21.76 (30 tablets) $23.10 (30 tablets) $35.40 (30 tablets) $30.00

$4.45 $2.88 (90 tablets) $3.20 (90 tablets) $5.22 (90 tablets) $8.68 (90 tablets) $4.89

1 September 2011

1 November 2011

1 February 2012

Losartan Losartan Losartan Losartan Losartan with hydrochlorothiazide Paracetamol Paracetamol

1 October 2011 1 October 2011 1 October 2011 1 October 2011

1 December 2011 1 December 2011 1 December 2011 1 December 2011

1 March 2012 1 March 2012 1 March 2012 1 March 2012

1 October 2011

1 December 2011

1 March 2012

$6.80 $2.21 Ethics Paracetamol (per 1,000 ml) (per 500 ml) (Multichem) $9.60 $9.38 Parafast (Arrow)

1 October 2011 1 November 2011

1 December 2011 1 January 2012

1 March 2012 1 April 2012

A422134 - qA18036

Page 4 of 10

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

3. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Inj 1 g; 5 vials Eye oint 0.1%; 3.5 g tube Cap 10 mg; 20 capsules, bottle Cap 40 mg; 20 capsules, bottle Hospital Supply Brand (Supplier) Azactam (BMS) Maxidex (Alcon) Ceenu (BMS) Ceenu (BMS) DV Limit 1% 1% 1% 1%

The decisions were as follows:

Chemical Name Aztreonam Dexamethasone Lomustine* Lomustine*

Pack price $131.00 $5.86 $132.59 $399.15

Listing date 1 July 2011 1 July 2011 -

Hospital Supply Status date 1 September 2011 1 September 2011 1 September 2011 1 September 2011

* Lomustine (PCT only) will remain listed at its current subsidy in Section B of the Pharmaceutical Schedule

4.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Presentation; Pack size and type Inj 500 mg; 1 vial Inj 25 mg per ml, 3 ml; 5 ampoules Suppos 12.5 mg; 10 suppositories, blister Suppos 25 mg; 10 suppositories, blister Suppos 50 mg; 10 suppositories, blister Current pack price $2.84 $12.00 $1.85 $2.22 $3.84 New pack price $2.37 $12.00 $1.85 $2.22 $3.84 Hospital Supply Brand (Supplier) Fortum (GSK) Voltaren (Novartis) Voltaren (Novartis) Voltaren (Novartis) Voltaren (Novartis) DV Limit 1% 1% 1% 1% 1% Date of price change 1 August 2011 Hospital Supply Status date 1 October 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

The decisions were as follows:

Chemical Name Ceftazidime Diclofenac sodium Diclofenac sodium Diclofenac sodium Diclofenac sodium

A422134 - qA18036

Page 5 of 10

---

Chemical Name Diclofenac sodium Diclofenac sodium Glyceryl trinitrate Glyceryl trinitrate Glyceryl trinitrate Lomustine* Lomustine* Metoclopramide hydrochloride Naphazoline hydrochloride Paracetamol

Presentation; Pack size and type Suppos 100 mg; 10 suppositories, blister Eye drops 1 mg per ml, 5 ml; 5 ml bottle Tab 600 mcg; 100 tablets, bottle TDDS 5 mg; 30 patches, sachet TDDS 10 mg; 30 patches, sachet Cap 10 mg; 20 capsules, bottle Cap 40 mg; 20 capsules, bottle Inj 5 mg per ml, 2 ml; 10 ampoules Eye drops 0.1%; 15 ml bottle Oral liq 250 mg per 5 ml; 1,000 ml bottle Inj 10 mg per ml, 0.5 ml; and inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.55 ml; 1 bottle Inj 1 mg per ml, 1 ml; 1 ampoule Inj 250 µg; 10 ampoules

Current pack price $6.36 $13.80 $8.00 $16.56 $19.60 $132.59 $399.15 $4.50 $4.15

New pack price $6.36 $13.80 $8.00 $16.56 $19.50 $132.59 $399.15 $4.50 $4.15

Hospital Supply Brand (Supplier) Voltaren (Novartis) Voltaren Ophtha (Novartis) Lycinate (Sigma) Nitroderm TTS (Novartis) Nitroderm TTS (Novartis) Ceenu (BMS) Ceenu (BMS) Pfizer (Pfizer) Naphcon Forte (Alcon) Paracare Double Strength (API)

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1%

Date of price change 1 July 2011 -

Hospital Supply Status date 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

$7.00

$6.70

20%

1 July 2011

1 September 2011

Sodium hyaluronate

$74.00

$74.00

DuoVisc (Alcon)

1%

-

1 September 2011

Tetracosactrin Tetracosactrin

$26.88 $177.18

$29.56 $177.18

Synacthen Depot (Novartis) Synacthen (Novartis)

1% 1%

1 July 2011 -

1 September 2011 1 September 2011

A422134 - qA18036

Page 6 of 10

---

Chemical Name Tropicamide Tropicamide Verapamil hydrochloride Verapamil hydrochloride

Presentation; Pack size and type Eye drops 0.5%; 15 ml bottle Eye drops 1%; 15 ml bottle Tab 40 mg; 100 tablets, blister Tab 80 mg; 100 tablets, blister

Current pack price $7.15 $8.66 $7.01 $11.74

New pack price $7.15 $8.66 $7.01 $11.74

Hospital Supply Brand (Supplier) Mydriacyl (Alcon) Mydriacyl (Alcon) Isoptin (Abbott) Isoptin (Abbott)

DV Limit 1% 1% 1% 1%

Date of price change -

Hospital Supply Status date 1 September 2011 1 September 2011 1 September 2011 1 September 2011

5.

Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

Presentation; Pack size and type Inj 1 g; 1 vial Inj 2 g; 1 vial Cap 50 mg; 28 capsules, blister Cap 150 mg; 1 capsule, blister Cap 200 mg; 28 capsules, blister Spray 400 mcg per dose; 250 dose aerosol spray Tab 12.5 mg; 90 tablets, blister Current pack price $5.63 $11.25 $6.82 $1.30 $19.05 New pack price $3.25 $6.49 $4.77 $0.91 $13.34 Hospital Supply Brand (Supplier) DBL Ceftazidime (Hospira) DBL Ceftazidime (Hospira) Flucoran (Douglas) Flucoran (Douglas) Flucoran (Douglas) Glytrin (AFT) Lostaar (Mylan) DV Limit 1% 1% 1% 1% 1% Date of listing/price change for tender winning brand 1 July 2011 1 July 2011 1 November 2011 1 November 2011 1 November 2011 Hospital Supply Status date (and delisting of other listed brands) 1 September 2011 1 September 2011 1 January 2012 1 January 2012 1 January 2012 Brand (Supplier) to be delisted Fortum (GSK) Fortum (GSK) Pacific (Mylan) Pacific (Mylan) Pacific (Mylan) Nitrolingual Pumpspray (Douglas) Cozaar (MSD)

The decisions were as follows:

Chemical Name

Ceftazidime Ceftazidime Fluconazole Fluconazole Fluconazole

Glyceryl trinitrate

$5.16 $17.40 (30 tablets)

$4.45 $2.88 (90 tablets)

1%

1 September 2011

1 November 2011

Losartan

1%

1 October 2011

1 December 2011

A422134 - qA18036

Page 7 of 10

---

Chemical Name

Presentation; Pack size and type Tab 25 mg; 90 tablets, blister Tab 50 mg; 90 tablets, blister Tab 100 mg; 90 tablets, blister Tab 50 mg; 30 tablets, blister Oral liq 120 mg per 5 ml; 500 ml bottle Tab 7.5 mg; 30 tablets, blister

Current pack price $21.76 (30 tablets) $23.10 (30 tablets) $35.40 (30 tablets) $30.00

New pack price $3.20 (90 tablets) $5.22 (90 tablets) $8.68 (90 tablets) $4.89

Hospital Supply Brand (Supplier) Lostaar (Mylan) Lostaar (Mylan) Lostaar (Mylan) Arrow-Losartan & Hydrochlorothiazide (Arrow)

DV Limit 1% 1% 1%

Date of listing/price change for tender winning brand 1 October 2011 1 October 2011 1 October 2011

Hospital Supply Status date (and delisting of other listed brands) 1 December 2011 1 December 2011 1 December 2011

Brand (Supplier) to be delisted Cozaar (MSD) Cozaar (MSD) Cozaar (MSD) Hyzaar (MSD) Paracare Junior (API) Apo-Zopiclone* (Apotex)

Losartan Losartan Losartan Losartan with hydrochlorothiazide Paracetamol Zopiclone

1%

1 October 2011

1 December 2011

$6.80 $2.21 Ethics Paracetamol (per 1,000 ml) (per 500 ml) (Multichem) $21.02 (per 500 tabs) $1.90 Apo-Zopiclone (Apotex)

20% 1%

1 October 2011 1 November 2011

1 December 2011 1 January 2012

* Apotex’s 500 tablet pack size will be delisted. Note that the April Tender Notification contained several errors regarding Apotex’s 30 tablet pack. The correct listing date is 1 November 2011, not 1 July 2011 and Apotex’s 30 tablet pack will be supplied in blister packs, not bottles.

A422134 - qA18036

Page 8 of 10

---

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2010/11 Invitation to Tender, dated 2 November 2010:

Chemical Name Acetazolamide Amikacin Amoxycillin Cefoxitin Ceftazidime Cefuroxime sodium Etoposide Fludarabine Galantamine Galantamine Galantamine Homatropine hydrobromide Metoclopramide hydrochloride Metronidazole Metronidazole Metronidazole Paracetamol* Pipobroman Polyvinyl alcohol Polyvinyl alcohol Line Item Cap modified-release 500 mg Inj 250 mg per ml, 2 ml Drops 125 mg per 1.25 ml Inj 1 g Inj 250 mg Inj 250 mg Inj 20 mg per ml, 5 ml Phosphate Tab 10 mg Modified release cap 8 mg Modified release cap 16 mg Modified release cap 24 mg Eye drops 2% Oral liq 5 mg per 5 ml Tab 200 mg Tab 400 mg Vaginal gel 0.75% Tab 500 mg Tab 25 mg Eye drops 1.4% Eye drops 1.4% Preservative free Chemical Name Polyvinyl alcohol Potassium bicarbonate Prochlorperazine Ranitidine hydrochloride Rivastigmine Rivastigmine Rivastigmine Rivastigmine Rizatriptan Rizatriptan Sodium hyaluronate Sulindac Sulindac Tamoxifen citrate Thioguanine Thiotepa Tiaprofenic Acid Tinidazole Tropicamide Line Item Eye drops 3% Tab 315 mg with sodium acid phosphate 1.937 g and sodium bicarbonate 350 mg Tab 5 mg Inj 25 mg per ml, 2 ml Cap 1.5 mg Cap 3 mg Cap 4.5 mg Cap 6 mg Tab 10 mg Tab 5 mg Inj 10 mg per ml, 0.35 ml; and inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.4 ml Tab 100 mg Tab 200 mg Tab 10 mg Tab 40 mg Inj 15 mg Tab 300 mg Tab 500 mg Eye drops single dose 1%

*Only the hospital tender for paracetamol tab 500 mg has been declined.

A422134 - qA18036

Page 9 of 10

---

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2009/10 Invitation to Tender, dated 4 December 2009:

Chemical Name Alfentanil Suxamethonium Ropivacaine Ropivacaine Ropivacaine Line Item Inj 0.5 mg per ml, 2 ml Inj 50 mg per ml, 2 ml Inj 2 mg per ml, 10 ml Inj 2 mg per ml, 20 ml Inj 7.5 mg per ml, 10 ml Chemical Name Ropivacaine Ropivacaine Ropivacaine Ropivacaine Ropivacaine Line Item Inj 7.5 mg per ml, 20 ml Inj 10 mg per ml, 10 ml Inj 10 mg per ml, 20 ml Inf 2 mg per ml, 100 ml Inf 2 mg per ml, 200 ml

For products included in the 2008/09 Invitation to Tender, 2009/10 Invitation to Tender and 2010/11 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A422134 - qA18036

Page 10 of 10